
Fernanda De Pinho Silveira MD
Professor of Medicine, University of Pittsburgh School of Medicine
Join to View Full Profile
3601 Fifth Avenue# 700Pittsburgh, PA 15213
Phone+1 412-647-7228
Fax+1 412-647-3162
Dr. Silveira is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UPMC Medical EducationFellowship, Infectious Disease, 2003 - 2005
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2000 - 2003
Faculdade de Medicina da Universidade Federal do Rio de JaneiroClass of 1998
Certifications & Licensure
PA State Medical License 2003 - 2026
American Board of Internal Medicine Infectious Disease
Clinical Trials
- Invasive Fungal Infections Surveillance Initiative Start of enrollment: 2005 Aug 01
- Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036) Start of enrollment: 2008 Jun 01
- Infectious Outcomes Following Pancreas Transplantation Start of enrollment: 2006 Apr 01
Publications & Presentations
PubMed
- 1 citationsVaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015-2020: US Hospitalized Adult Influenza Vaccine Effectiveness Netw...Po-Han Huang, Mary Patricia Nowalk, Richard K Zimmerman, Samantha M Olson, H Keipp Talbot
Human Vaccines & Immunotherapeutics. 2025-12-01 - Severity of Clinical Presentation and Outcomes in Hospitalized Adult Patients with Influenza by Type and Subtype, United States-2017-2020.Seana Cleary, Nathaniel M Lewis, H Keipp Talbot, Yuwei Zhu, Emily T Martin
Clinical Infectious Diseases. 2025-09-26 - 6 citationsDalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial.Nicholas A Turner, Toshimitsu Hamasaki, Sarah B Doernberg, Thomas P Lodise, Heather A King
JAMA. 2025-08-13
Press Mentions
Takeda Announces Publication of Data from SOLSTICE, a Pivotal Phase 3 Trial for LIVTENCITY™ (Maribavir) in Post-Transplant Recipients with Cytomegalovirus (CMV) Infection (Refractory, with or Without Resistance)December 7th, 2021
More Organs Available for Transplant Because of Opioid EpidemicApril 18th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









